financetom
Business
financetom
/
Business
/
Zebra Technologies Q1 Adjusted EPS, Sales Rise; Q2, Full-Year Guidance Issued -- Shares Up Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zebra Technologies Q1 Adjusted EPS, Sales Rise; Q2, Full-Year Guidance Issued -- Shares Up Pre-Bell
May 25, 2025 8:41 PM

07:18 AM EDT, 04/29/2025 (MT Newswires) -- Zebra Technologies ( ZBRA ) reported Q1 non-GAAP net income Tuesday of $4.02 per diluted share, up from $2.84 a year earlier.

Analysts polled by FactSet expected $3.62.

Net sales for the quarter ended March 29 was $1.31 billion, up from $1.18 billion a year earlier.

Analysts surveyed by FactSet expected $1.29 billion.

The company expects Q2 non-GAAP earnings of $3.00 to $3.50 per diluted share. Analysts expect $3.52. The company expects Q2 sales growth of between 4% and 7%. Analysts expect $1.28 billion.

The company said it expects full-year 2025 non-GAAP earnings of $13.75 to $14.75 per diluted share. Analysts surveyed by FactSet expect $15.12. The company maintained its sales growth expectations for full-year 2025 of between 3% and 7%. Analysts expect $5.24 billion.

Shares were up nearly 8% in premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Adient Prices $795 Million of 7.50% Senior Notes Due 2023, Discloses Plans to Redeem 2026 Notes
Adient Prices $795 Million of 7.50% Senior Notes Due 2023, Discloses Plans to Redeem 2026 Notes
Jan 30, 2025
05:47 PM EST, 01/30/2025 (MT Newswires) -- Adient (ADNT), through a subsidiary, late Thursday said it has priced a $795 million private placement of 7.50% senior unsecured notes maturing in 2033 at par. The vehicle seating manufacturer said it expects to use net proceeds from the offering, together with cash on hand, to redeem its existing 4.875% senior unsecured notes...
US FDA approves Vertex's non-opioid painkiller
US FDA approves Vertex's non-opioid painkiller
Jan 30, 2025
Jan 30 (Reuters) - The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' ( VRTX ) drug to treat acute pain, the health regulator said on Thursday, offering an alternative to addictive opioid painkillers that have fueled a national crisis. ...
Emerald Completes $515 Million Loan Refinancing, Extends Credit Maturity
Emerald Completes $515 Million Loan Refinancing, Extends Credit Maturity
Jan 30, 2025
05:56 PM EST, 01/30/2025 (MT Newswires) -- Emerald Holding ( EEX ) said Thursday it completed the refinancing of its existing first lien term loan with a $515 million senior secured term loan facility. The new upsized seven-year facility matures on Jan. 30, 2032, according to the company. Additionally, Emerald extended the maturity of its $110 million senior secured revolving...
Gen Digital beats third-quarter revenue estimates on strong demand for cybersecurity tools
Gen Digital beats third-quarter revenue estimates on strong demand for cybersecurity tools
Jan 30, 2025
Jan 28 (Reuters) - Gen Digital ( GEN ) topped Wall Street estimates for third-quarter revenue and profit on Thursday, driven by strong demand for its cybersecurity tools. A surge in digital scams and high-profile hacks is fueling demand for Gen Digital's ( GEN ) cybersecurity solutions, as businesses adopt artificial intelligence (AI) technology and increasingly deploy robust security measures...
Copyright 2023-2026 - www.financetom.com All Rights Reserved